img

Global Cefuroxime Sodium Injection Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Cefuroxime Sodium Injection Market Research Report 2024

Cefuroxime sodium injection is used for various infections caused by sensitive bacteria, especially respiratory tract infections. COVID-19 has erupted in the world, and the demand for anti-infective drugs is rising, and these drugs are in short supply.
According to Mr Accuracy reports’s new survey, global Cefuroxime Sodium Injection market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Cefuroxime Sodium Injection market research.
Key manufacturers engaged in the Cefuroxime Sodium Injection industry include Hikma, Sagent, Pfizer, Teligent, SteriMax, Fresenius Kabi, Aglobal Care, Guangzhou Baiyunshan Tianxin Pharmaceutical and Sinopharm Weiqida Pharmaceutical, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Cefuroxime Sodium Injection were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Cefuroxime Sodium Injection market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Cefuroxime Sodium Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Hikma
Sagent
Pfizer
Teligent
SteriMax
Fresenius Kabi
Aglobal Care
Guangzhou Baiyunshan Tianxin Pharmaceutical
Sinopharm Weiqida Pharmaceutical
Shanghai New Asia Pharmacetical
Harbin Pharmaceutical Group
Youcare Pharmaceutical Group
Weikang Pharmaceutical
Segment by Type
0.25g/vial
0.5g/vial
0.75g/vial
1.5g/vial

Segment by Application


Hospital
Clinic
Others

Consumption by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Cefuroxime Sodium Injection report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Cefuroxime Sodium Injection Market Overview
1.1 Product Overview and Scope of Cefuroxime Sodium Injection
1.2 Cefuroxime Sodium Injection Segment by Type
1.2.1 Global Cefuroxime Sodium Injection Market Value Comparison by Type (2024-2034)
1.2.2 0.25g/vial
1.2.3 0.5g/vial
1.2.4 0.75g/vial
1.2.5 1.5g/vial
1.3 Cefuroxime Sodium Injection Segment by Application
1.3.1 Global Cefuroxime Sodium Injection Market Value by Application: (2024-2034)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Cefuroxime Sodium Injection Market Size Estimates and Forecasts
1.4.1 Global Cefuroxime Sodium Injection Revenue 2018-2034
1.4.2 Global Cefuroxime Sodium Injection Sales 2018-2034
1.4.3 Global Cefuroxime Sodium Injection Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Cefuroxime Sodium Injection Market Competition by Manufacturers
2.1 Global Cefuroxime Sodium Injection Sales Market Share by Manufacturers (2018-2024)
2.2 Global Cefuroxime Sodium Injection Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Cefuroxime Sodium Injection Average Price by Manufacturers (2018-2024)
2.4 Global Cefuroxime Sodium Injection Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Cefuroxime Sodium Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Cefuroxime Sodium Injection, Product Type & Application
2.7 Cefuroxime Sodium Injection Market Competitive Situation and Trends
2.7.1 Cefuroxime Sodium Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Cefuroxime Sodium Injection Players Market Share by Revenue
2.7.3 Global Cefuroxime Sodium Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Cefuroxime Sodium Injection Retrospective Market Scenario by Region
3.1 Global Cefuroxime Sodium Injection Market Size by Region: 2018 Versus 2022 Versus 2034
3.2 Global Cefuroxime Sodium Injection Global Cefuroxime Sodium Injection Sales by Region: 2018-2034
3.2.1 Global Cefuroxime Sodium Injection Sales by Region: 2018-2024
3.2.2 Global Cefuroxime Sodium Injection Sales by Region: 2024-2034
3.3 Global Cefuroxime Sodium Injection Global Cefuroxime Sodium Injection Revenue by Region: 2018-2034
3.3.1 Global Cefuroxime Sodium Injection Revenue by Region: 2018-2024
3.3.2 Global Cefuroxime Sodium Injection Revenue by Region: 2024-2034
3.4 North America Cefuroxime Sodium Injection Market Facts & Figures by Country
3.4.1 North America Cefuroxime Sodium Injection Market Size by Country: 2018 VS 2022 VS 2034
3.4.2 North America Cefuroxime Sodium Injection Sales by Country (2018-2034)
3.4.3 North America Cefuroxime Sodium Injection Revenue by Country (2018-2034)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Cefuroxime Sodium Injection Market Facts & Figures by Country
3.5.1 Europe Cefuroxime Sodium Injection Market Size by Country: 2018 VS 2022 VS 2034
3.5.2 Europe Cefuroxime Sodium Injection Sales by Country (2018-2034)
3.5.3 Europe Cefuroxime Sodium Injection Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Cefuroxime Sodium Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Cefuroxime Sodium Injection Market Size by Country: 2018 VS 2022 VS 2034
3.6.2 Asia Pacific Cefuroxime Sodium Injection Sales by Country (2018-2034)
3.6.3 Asia Pacific Cefuroxime Sodium Injection Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Cefuroxime Sodium Injection Market Facts & Figures by Country
3.7.1 Latin America Cefuroxime Sodium Injection Market Size by Country: 2018 VS 2022 VS 2034
3.7.2 Latin America Cefuroxime Sodium Injection Sales by Country (2018-2034)
3.7.3 Latin America Cefuroxime Sodium Injection Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Cefuroxime Sodium Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Cefuroxime Sodium Injection Market Size by Country: 2018 VS 2022 VS 2034
3.8.2 Middle East and Africa Cefuroxime Sodium Injection Sales by Country (2018-2034)
3.8.3 Middle East and Africa Cefuroxime Sodium Injection Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Cefuroxime Sodium Injection Sales by Type (2018-2034)
4.1.1 Global Cefuroxime Sodium Injection Sales by Type (2018-2024)
4.1.2 Global Cefuroxime Sodium Injection Sales by Type (2024-2034)
4.1.3 Global Cefuroxime Sodium Injection Sales Market Share by Type (2018-2034)
4.2 Global Cefuroxime Sodium Injection Revenue by Type (2018-2034)
4.2.1 Global Cefuroxime Sodium Injection Revenue by Type (2018-2024)
4.2.2 Global Cefuroxime Sodium Injection Revenue by Type (2024-2034)
4.2.3 Global Cefuroxime Sodium Injection Revenue Market Share by Type (2018-2034)
4.3 Global Cefuroxime Sodium Injection Price by Type (2018-2034)
5 Segment by Application
5.1 Global Cefuroxime Sodium Injection Sales by Application (2018-2034)
5.1.1 Global Cefuroxime Sodium Injection Sales by Application (2018-2024)
5.1.2 Global Cefuroxime Sodium Injection Sales by Application (2024-2034)
5.1.3 Global Cefuroxime Sodium Injection Sales Market Share by Application (2018-2034)
5.2 Global Cefuroxime Sodium Injection Revenue by Application (2018-2034)
5.2.1 Global Cefuroxime Sodium Injection Revenue by Application (2018-2024)
5.2.2 Global Cefuroxime Sodium Injection Revenue by Application (2024-2034)
5.2.3 Global Cefuroxime Sodium Injection Revenue Market Share by Application (2018-2034)
5.3 Global Cefuroxime Sodium Injection Price by Application (2018-2034)
6 Key Companies Profiled
6.1 Hikma
6.1.1 Hikma Corporation Information
6.1.2 Hikma Description and Business Overview
6.1.3 Hikma Cefuroxime Sodium Injection Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Hikma Cefuroxime Sodium Injection Product Portfolio
6.1.5 Hikma Recent Developments/Updates
6.2 Sagent
6.2.1 Sagent Corporation Information
6.2.2 Sagent Description and Business Overview
6.2.3 Sagent Cefuroxime Sodium Injection Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Sagent Cefuroxime Sodium Injection Product Portfolio
6.2.5 Sagent Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Corporation Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Cefuroxime Sodium Injection Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Pfizer Cefuroxime Sodium Injection Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Teligent
6.4.1 Teligent Corporation Information
6.4.2 Teligent Description and Business Overview
6.4.3 Teligent Cefuroxime Sodium Injection Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Teligent Cefuroxime Sodium Injection Product Portfolio
6.4.5 Teligent Recent Developments/Updates
6.5 SteriMax
6.5.1 SteriMax Corporation Information
6.5.2 SteriMax Description and Business Overview
6.5.3 SteriMax Cefuroxime Sodium Injection Sales, Revenue and Gross Margin (2018-2024)
6.5.4 SteriMax Cefuroxime Sodium Injection Product Portfolio
6.5.5 SteriMax Recent Developments/Updates
6.6 Fresenius Kabi
6.6.1 Fresenius Kabi Corporation Information
6.6.2 Fresenius Kabi Description and Business Overview
6.6.3 Fresenius Kabi Cefuroxime Sodium Injection Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Fresenius Kabi Cefuroxime Sodium Injection Product Portfolio
6.6.5 Fresenius Kabi Recent Developments/Updates
6.7 Aglobal Care
6.6.1 Aglobal Care Corporation Information
6.6.2 Aglobal Care Description and Business Overview
6.6.3 Aglobal Care Cefuroxime Sodium Injection Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Aglobal Care Cefuroxime Sodium Injection Product Portfolio
6.7.5 Aglobal Care Recent Developments/Updates
6.8 Guangzhou Baiyunshan Tianxin Pharmaceutical
6.8.1 Guangzhou Baiyunshan Tianxin Pharmaceutical Corporation Information
6.8.2 Guangzhou Baiyunshan Tianxin Pharmaceutical Description and Business Overview
6.8.3 Guangzhou Baiyunshan Tianxin Pharmaceutical Cefuroxime Sodium Injection Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Guangzhou Baiyunshan Tianxin Pharmaceutical Cefuroxime Sodium Injection Product Portfolio
6.8.5 Guangzhou Baiyunshan Tianxin Pharmaceutical Recent Developments/Updates
6.9 Sinopharm Weiqida Pharmaceutical
6.9.1 Sinopharm Weiqida Pharmaceutical Corporation Information
6.9.2 Sinopharm Weiqida Pharmaceutical Description and Business Overview
6.9.3 Sinopharm Weiqida Pharmaceutical Cefuroxime Sodium Injection Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Sinopharm Weiqida Pharmaceutical Cefuroxime Sodium Injection Product Portfolio
6.9.5 Sinopharm Weiqida Pharmaceutical Recent Developments/Updates
6.10 Shanghai New Asia Pharmacetical
6.10.1 Shanghai New Asia Pharmacetical Corporation Information
6.10.2 Shanghai New Asia Pharmacetical Description and Business Overview
6.10.3 Shanghai New Asia Pharmacetical Cefuroxime Sodium Injection Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Shanghai New Asia Pharmacetical Cefuroxime Sodium Injection Product Portfolio
6.10.5 Shanghai New Asia Pharmacetical Recent Developments/Updates
6.11 Harbin Pharmaceutical Group
6.11.1 Harbin Pharmaceutical Group Corporation Information
6.11.2 Harbin Pharmaceutical Group Cefuroxime Sodium Injection Description and Business Overview
6.11.3 Harbin Pharmaceutical Group Cefuroxime Sodium Injection Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Harbin Pharmaceutical Group Cefuroxime Sodium Injection Product Portfolio
6.11.5 Harbin Pharmaceutical Group Recent Developments/Updates
6.12 Youcare Pharmaceutical Group
6.12.1 Youcare Pharmaceutical Group Corporation Information
6.12.2 Youcare Pharmaceutical Group Cefuroxime Sodium Injection Description and Business Overview
6.12.3 Youcare Pharmaceutical Group Cefuroxime Sodium Injection Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Youcare Pharmaceutical Group Cefuroxime Sodium Injection Product Portfolio
6.12.5 Youcare Pharmaceutical Group Recent Developments/Updates
6.13 Weikang Pharmaceutical
6.13.1 Weikang Pharmaceutical Corporation Information
6.13.2 Weikang Pharmaceutical Cefuroxime Sodium Injection Description and Business Overview
6.13.3 Weikang Pharmaceutical Cefuroxime Sodium Injection Sales, Revenue and Gross Margin (2018-2024)
6.13.4 Weikang Pharmaceutical Cefuroxime Sodium Injection Product Portfolio
6.13.5 Weikang Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Cefuroxime Sodium Injection Industry Chain Analysis
7.2 Cefuroxime Sodium Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Cefuroxime Sodium Injection Production Mode & Process
7.4 Cefuroxime Sodium Injection Sales and Marketing
7.4.1 Cefuroxime Sodium Injection Sales Channels
7.4.2 Cefuroxime Sodium Injection Distributors
7.5 Cefuroxime Sodium Injection Customers
8 Cefuroxime Sodium Injection Market Dynamics
8.1 Cefuroxime Sodium Injection Industry Trends
8.2 Cefuroxime Sodium Injection Market Drivers
8.3 Cefuroxime Sodium Injection Market Challenges
8.4 Cefuroxime Sodium Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Cefuroxime Sodium Injection Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Cefuroxime Sodium Injection Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Cefuroxime Sodium Injection Market Competitive Situation by Manufacturers in 2022
Table 4. Global Cefuroxime Sodium Injection Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Cefuroxime Sodium Injection Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Cefuroxime Sodium Injection Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Cefuroxime Sodium Injection Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Cefuroxime Sodium Injection Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Cefuroxime Sodium Injection, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Cefuroxime Sodium Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Cefuroxime Sodium Injection, Product Type & Application
Table 12. Global Key Manufacturers of Cefuroxime Sodium Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Cefuroxime Sodium Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cefuroxime Sodium Injection as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Cefuroxime Sodium Injection Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Table 17. Global Cefuroxime Sodium Injection Sales by Region (2018-2024) & (K Units)
Table 18. Global Cefuroxime Sodium Injection Sales Market Share by Region (2018-2024)
Table 19. Global Cefuroxime Sodium Injection Sales by Region (2024-2034) & (K Units)
Table 20. Global Cefuroxime Sodium Injection Sales Market Share by Region (2024-2034)
Table 21. Global Cefuroxime Sodium Injection Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Cefuroxime Sodium Injection Revenue Market Share by Region (2018-2024)
Table 23. Global Cefuroxime Sodium Injection Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Cefuroxime Sodium Injection Revenue Market Share by Region (2024-2034)
Table 25. North America Cefuroxime Sodium Injection Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 26. North America Cefuroxime Sodium Injection Sales by Country (2018-2024) & (K Units)
Table 27. North America Cefuroxime Sodium Injection Sales by Country (2024-2034) & (K Units)
Table 28. North America Cefuroxime Sodium Injection Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Cefuroxime Sodium Injection Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Cefuroxime Sodium Injection Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 31. Europe Cefuroxime Sodium Injection Sales by Country (2018-2024) & (K Units)
Table 32. Europe Cefuroxime Sodium Injection Sales by Country (2024-2034) & (K Units)
Table 33. Europe Cefuroxime Sodium Injection Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Cefuroxime Sodium Injection Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Cefuroxime Sodium Injection Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific Cefuroxime Sodium Injection Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Cefuroxime Sodium Injection Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Cefuroxime Sodium Injection Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Cefuroxime Sodium Injection Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Cefuroxime Sodium Injection Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America Cefuroxime Sodium Injection Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Cefuroxime Sodium Injection Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Cefuroxime Sodium Injection Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Cefuroxime Sodium Injection Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Cefuroxime Sodium Injection Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa Cefuroxime Sodium Injection Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Cefuroxime Sodium Injection Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Cefuroxime Sodium Injection Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Cefuroxime Sodium Injection Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Cefuroxime Sodium Injection Sales (K Units) by Type (2018-2024)
Table 51. Global Cefuroxime Sodium Injection Sales (K Units) by Type (2024-2034)
Table 52. Global Cefuroxime Sodium Injection Sales Market Share by Type (2018-2024)
Table 53. Global Cefuroxime Sodium Injection Sales Market Share by Type (2024-2034)
Table 54. Global Cefuroxime Sodium Injection Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Cefuroxime Sodium Injection Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Cefuroxime Sodium Injection Revenue Market Share by Type (2018-2024)
Table 57. Global Cefuroxime Sodium Injection Revenue Market Share by Type (2024-2034)
Table 58. Global Cefuroxime Sodium Injection Price (US$/Unit) by Type (2018-2024)
Table 59. Global Cefuroxime Sodium Injection Price (US$/Unit) by Type (2024-2034)
Table 60. Global Cefuroxime Sodium Injection Sales (K Units) by Application (2018-2024)
Table 61. Global Cefuroxime Sodium Injection Sales (K Units) by Application (2024-2034)
Table 62. Global Cefuroxime Sodium Injection Sales Market Share by Application (2018-2024)
Table 63. Global Cefuroxime Sodium Injection Sales Market Share by Application (2024-2034)
Table 64. Global Cefuroxime Sodium Injection Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Cefuroxime Sodium Injection Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Cefuroxime Sodium Injection Revenue Market Share by Application (2018-2024)
Table 67. Global Cefuroxime Sodium Injection Revenue Market Share by Application (2024-2034)
Table 68. Global Cefuroxime Sodium Injection Price (US$/Unit) by Application (2018-2024)
Table 69. Global Cefuroxime Sodium Injection Price (US$/Unit) by Application (2024-2034)
Table 70. Hikma Corporation Information
Table 71. Hikma Description and Business Overview
Table 72. Hikma Cefuroxime Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. Hikma Cefuroxime Sodium Injection Product
Table 74. Hikma Recent Developments/Updates
Table 75. Sagent Corporation Information
Table 76. Sagent Description and Business Overview
Table 77. Sagent Cefuroxime Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. Sagent Cefuroxime Sodium Injection Product
Table 79. Sagent Recent Developments/Updates
Table 80. Pfizer Corporation Information
Table 81. Pfizer Description and Business Overview
Table 82. Pfizer Cefuroxime Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 83. Pfizer Cefuroxime Sodium Injection Product
Table 84. Pfizer Recent Developments/Updates
Table 85. Teligent Corporation Information
Table 86. Teligent Description and Business Overview
Table 87. Teligent Cefuroxime Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 88. Teligent Cefuroxime Sodium Injection Product
Table 89. Teligent Recent Developments/Updates
Table 90. SteriMax Corporation Information
Table 91. SteriMax Description and Business Overview
Table 92. SteriMax Cefuroxime Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 93. SteriMax Cefuroxime Sodium Injection Product
Table 94. SteriMax Recent Developments/Updates
Table 95. Fresenius Kabi Corporation Information
Table 96. Fresenius Kabi Description and Business Overview
Table 97. Fresenius Kabi Cefuroxime Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 98. Fresenius Kabi Cefuroxime Sodium Injection Product
Table 99. Fresenius Kabi Recent Developments/Updates
Table 100. Aglobal Care Corporation Information
Table 101. Aglobal Care Description and Business Overview
Table 102. Aglobal Care Cefuroxime Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 103. Aglobal Care Cefuroxime Sodium Injection Product
Table 104. Aglobal Care Recent Developments/Updates
Table 105. Guangzhou Baiyunshan Tianxin Pharmaceutical Corporation Information
Table 106. Guangzhou Baiyunshan Tianxin Pharmaceutical Description and Business Overview
Table 107. Guangzhou Baiyunshan Tianxin Pharmaceutical Cefuroxime Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 108. Guangzhou Baiyunshan Tianxin Pharmaceutical Cefuroxime Sodium Injection Product
Table 109. Guangzhou Baiyunshan Tianxin Pharmaceutical Recent Developments/Updates
Table 110. Sinopharm Weiqida Pharmaceutical Corporation Information
Table 111. Sinopharm Weiqida Pharmaceutical Description and Business Overview
Table 112. Sinopharm Weiqida Pharmaceutical Cefuroxime Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. Sinopharm Weiqida Pharmaceutical Cefuroxime Sodium Injection Product
Table 114. Sinopharm Weiqida Pharmaceutical Recent Developments/Updates
Table 115. Shanghai New Asia Pharmacetical Corporation Information
Table 116. Shanghai New Asia Pharmacetical Description and Business Overview
Table 117. Shanghai New Asia Pharmacetical Cefuroxime Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. Shanghai New Asia Pharmacetical Cefuroxime Sodium Injection Product
Table 119. Shanghai New Asia Pharmacetical Recent Developments/Updates
Table 120. Harbin Pharmaceutical Group Corporation Information
Table 121. Harbin Pharmaceutical Group Description and Business Overview
Table 122. Harbin Pharmaceutical Group Cefuroxime Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. Harbin Pharmaceutical Group Cefuroxime Sodium Injection Product
Table 124. Harbin Pharmaceutical Group Recent Developments/Updates
Table 125. Youcare Pharmaceutical Group Corporation Information
Table 126. Youcare Pharmaceutical Group Description and Business Overview
Table 127. Youcare Pharmaceutical Group Cefuroxime Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 128. Youcare Pharmaceutical Group Cefuroxime Sodium Injection Product
Table 129. Youcare Pharmaceutical Group Recent Developments/Updates
Table 130. Weikang Pharmaceutical Corporation Information
Table 131. Weikang Pharmaceutical Description and Business Overview
Table 132. Weikang Pharmaceutical Cefuroxime Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 133. Weikang Pharmaceutical Cefuroxime Sodium Injection Product
Table 134. Weikang Pharmaceutical Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Cefuroxime Sodium Injection Distributors List
Table 138. Cefuroxime Sodium Injection Customers List
Table 139. Cefuroxime Sodium Injection Market Trends
Table 140. Cefuroxime Sodium Injection Market Drivers
Table 141. Cefuroxime Sodium Injection Market Challenges
Table 142. Cefuroxime Sodium Injection Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Cefuroxime Sodium Injection
Figure 2. Global Cefuroxime Sodium Injection Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Cefuroxime Sodium Injection Market Share by Type in 2022 & 2034
Figure 4. 0.25g/vial Product Picture
Figure 5. 0.5g/vial Product Picture
Figure 6. 0.75g/vial Product Picture
Figure 7. 1.5g/vial Product Picture
Figure 8. Global Cefuroxime Sodium Injection Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 9. Global Cefuroxime Sodium Injection Market Share by Application in 2022 & 2034
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Others
Figure 13. Global Cefuroxime Sodium Injection Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 14. Global Cefuroxime Sodium Injection Market Size (2018-2034) & (US$ Million)
Figure 15. Global Cefuroxime Sodium Injection Sales (2018-2034) & (K Units)
Figure 16. Global Cefuroxime Sodium Injection Average Price (US$/Unit) & (2018-2034)
Figure 17. Cefuroxime Sodium Injection Report Years Considered
Figure 18. Cefuroxime Sodium Injection Sales Share by Manufacturers in 2022
Figure 19. Global Cefuroxime Sodium Injection Revenue Share by Manufacturers in 2022
Figure 20. The Global 5 and 10 Largest Cefuroxime Sodium Injection Players: Market Share by Revenue in 2022
Figure 21. Cefuroxime Sodium Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 22. Global Cefuroxime Sodium Injection Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Figure 23. North America Cefuroxime Sodium Injection Sales Market Share by Country (2018-2034)
Figure 24. North America Cefuroxime Sodium Injection Revenue Market Share by Country (2018-2034)
Figure 25. U.S. Cefuroxime Sodium Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 26. Canada Cefuroxime Sodium Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 27. Europe Cefuroxime Sodium Injection Sales Market Share by Country (2018-2034)
Figure 28. Europe Cefuroxime Sodium Injection Revenue Market Share by Country (2018-2034)
Figure 29. Germany Cefuroxime Sodium Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 30. France Cefuroxime Sodium Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. U.K. Cefuroxime Sodium Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 32. Italy Cefuroxime Sodium Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 33. Russia Cefuroxime Sodium Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 34. Asia Pacific Cefuroxime Sodium Injection Sales Market Share by Region (2018-2034)
Figure 35. Asia Pacific Cefuroxime Sodium Injection Revenue Market Share by Region (2018-2034)
Figure 36. China Cefuroxime Sodium Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. Japan Cefuroxime Sodium Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. South Korea Cefuroxime Sodium Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. India Cefuroxime Sodium Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. Australia Cefuroxime Sodium Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Taiwan Cefuroxime Sodium Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. Indonesia Cefuroxime Sodium Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. Thailand Cefuroxime Sodium Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 44. Malaysia Cefuroxime Sodium Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 45. Philippines Cefuroxime Sodium Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 46. Latin America Cefuroxime Sodium Injection Sales Market Share by Country (2018-2034)
Figure 47. Latin America Cefuroxime Sodium Injection Revenue Market Share by Country (2018-2034)
Figure 48. Mexico Cefuroxime Sodium Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 49. Brazil Cefuroxime Sodium Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 50. Argentina Cefuroxime Sodium Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 51. Middle East & Africa Cefuroxime Sodium Injection Sales Market Share by Country (2018-2034)
Figure 52. Middle East & Africa Cefuroxime Sodium Injection Revenue Market Share by Country (2018-2034)
Figure 53. Turkey Cefuroxime Sodium Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 54. Saudi Arabia Cefuroxime Sodium Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 55. UAE Cefuroxime Sodium Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 56. Global Sales Market Share of Cefuroxime Sodium Injection by Type (2018-2034)
Figure 57. Global Revenue Market Share of Cefuroxime Sodium Injection by Type (2018-2034)
Figure 58. Global Cefuroxime Sodium Injection Price (US$/Unit) by Type (2018-2034)
Figure 59. Global Sales Market Share of Cefuroxime Sodium Injection by Application (2018-2034)
Figure 60. Global Revenue Market Share of Cefuroxime Sodium Injection by Application (2018-2034)
Figure 61. Global Cefuroxime Sodium Injection Price (US$/Unit) by Application (2018-2034)
Figure 62. Cefuroxime Sodium Injection Value Chain
Figure 63. Cefuroxime Sodium Injection Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed